Skip to content

GSK cuts abacavir price by 31% for developing countries

French study further mystifies causes of bone loss in people with HIV

Spanish study shows the benefits of starting HIV treatment at higher CD4 cell counts

Gene associated with efavirenz and nevirapine rash identified

Key test of kidney function has poor accuracy in patients with HIV

CROI: Choice of nucleoside analogue in co-infection: tenofovir associated with better response to HCV therapy

CROI: Kivexa and Truvada have similar efficacy and safety

FDA approves generic atazanavir

Boehringer-Ingelheim begins trial of once-daily extended release nevirapine